Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways.

Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways.

Item
http://www.wikidata.org/entity/Q39750564
Enteral sesame oil therapeutically relieves disease severity in rat experimental osteoarthritisOxidative stress participates in quadriceps muscle dysfunction during the initiation of osteoarthritis in ratsMuscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.Ocimum gratissimum Aqueous Extract Protects H9c2 Myocardiac Cells from H(2)O(2)-Induced Cell Apoptosis through Akt Signalling.Essential amino acid enriched high-protein enteral nutrition modulates insulin-like growth factor-1 system function in a rat model of trauma-hemorrhagic shock.Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null MiceReactive oxygen species in skeletal muscle signaling.Circulating Biomarkers for Duchenne Muscular Dystrophy.IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.Sodium fluoride suppress proliferation and induce apoptosis through decreased insulin-like growth factor-I expression and oxidative stress in primary cultured mouse osteoblasts.Independent and additive effects of atenolol and methionine restriction on lowering rat heart mitochondria oxidative stress.Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway.Photobiomodulation on Bax and Bcl-2 Proteins and SIRT1/PGC-1αAxis mRNA Expression Levels of Aging Rat Skeletal Muscle
P2860

Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways.

Item
http://www.wikidata.org/entity/Q39750564
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@en
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@nl
type
label
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@en
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@nl
prefLabel
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@en
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Pretreatment with insulin-like ...... /Akt and ERK1/2 MAPK pathways.
@en
P2093
P2860
P2888
P304
P31
P356
10.1038/LABINVEST.2009.139
P433
P478
P577
P5875
P698
P921